BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8669668)

  • 1. Pharmacokinetics of propofol in adult patients undergoing coronary revascularization. The Multicenter Study of Perioperative Ischemia Research Group.
    Bailey JM; Mora CT; Shafer SL
    Anesthesiology; 1996 Jun; 84(6):1288-97. PubMed ID: 8669668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of computer-controlled alfentanil administration in children undergoing cardiac surgery.
    Fiset P; Mathers L; Engstrom R; Fitzgerald D; Brand SC; Hsu F; Shafer SL
    Anesthesiology; 1995 Nov; 83(5):944-55. PubMed ID: 7486179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cardiopulmonary bypass on sufentanil pharmacokinetics in patients undergoing coronary artery bypass surgery.
    Hudson RJ; Thomson IR; Jassal R
    Anesthesiology; 2004 Oct; 101(4):862-71. PubMed ID: 15448518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity Does Not Affect Propofol Pharmacokinetics During Hypothermic Cardiopulmonary Bypass.
    El-Baraky IA; Abbassi MM; Marei TA; Sabry NA
    J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):876-83. PubMed ID: 27236490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic model-driven infusion of sufentanil and midazolam during cardiac surgery: assessment of the prospective predictive accuracy and the quality of anesthesia.
    Barvais L; Heitz D; Schmartz D; Maes V; Coussaert E; Cantraine F; d'Hollander A
    J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):402-8. PubMed ID: 10972605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary bypass has minimal effects on the pharmacokinetics of fentanyl in adults.
    Hudson RJ; Thomson IR; Jassal R; Peterson DJ; Brown AD; Freedman JI
    Anesthesiology; 2003 Oct; 99(4):847-54. PubMed ID: 14508316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of propofol infusion in Asian patients undergoing coronary artery bypass grafting.
    Lee HS; Khoo YM; Chua BC; Ng AS; Tan SS; Chew SL
    Ther Drug Monit; 1995 Aug; 17(4):336-41. PubMed ID: 7482686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in total and unbound concentrations of sufentanil during target controlled infusion for cardiac surgery with cardiopulmonary bypass.
    Jeleazcov C; Saari TI; Ihmsen H; Schüttler J; Fechner J
    Br J Anaesth; 2012 Nov; 109(5):698-706. PubMed ID: 22831891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of propofol in children using three different data analysis approaches.
    Kataria BK; Ved SA; Nicodemus HF; Hoy GR; Lea D; Dubois MY; Mandema JW; Shafer SL
    Anesthesiology; 1994 Jan; 80(1):104-22. PubMed ID: 8291699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of propofol: a multicenter study.
    Schüttler J; Ihmsen H
    Anesthesiology; 2000 Mar; 92(3):727-38. PubMed ID: 10719952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of TCI Propofol Using the Schnider Model for Cardiac Surgery on Cardiopulmonary Bypass-A Pilot Study.
    Lee AKY; Kong AYH; Kong CF
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):723-730. PubMed ID: 29225156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of fentanyl pharmacokinetics in patients undergoing coronary artery bypass grafting.
    Hudson RJ; Thomson IR; Henderson BT; Singh K; Harding G; Peterson DJ
    Can J Anaesth; 2002 Apr; 49(4):388-92. PubMed ID: 11927479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cardiopulmonary bypass on propofol pharmacokinetics and bispectral index during coronary surgery.
    Barbosa RA; Santos SR; White PF; Pereira VA; Silva Filho CR; Malbouisson LM; Carmona MJ
    Clinics (Sao Paulo); 2009; 64(3):215-21. PubMed ID: 19330248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of propofol/alfentanil infusions for sedation in ICU patients.
    Frenkel C; Schuttler J; Ihmsen H; Heye H; Rommelsheim K
    Intensive Care Med; 1995 Dec; 21(12):981-8. PubMed ID: 8750122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-effects modeling of the influence of alfentanil on propofol pharmacokinetics.
    Mertens MJ; Olofsen E; Burm AG; Bovill JG; Vuyk J
    Anesthesiology; 2004 Apr; 100(4):795-805. PubMed ID: 15087613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of an infusion of propofol during cardiac surgery.
    Massey NJ; Sherry KM; Oldroyd S; Peacock JE
    Br J Anaesth; 1990 Oct; 65(4):475-9. PubMed ID: 2248815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of target controlled infusion to derive age and gender covariates for propofol clearance.
    White M; Kenny GN; Schraag S
    Clin Pharmacokinet; 2008; 47(2):119-27. PubMed ID: 18193918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting.
    Zomorodi K; Donner A; Somma J; Barr J; Sladen R; Ramsay J; Geller E; Shafer SL
    Anesthesiology; 1998 Dec; 89(6):1418-29. PubMed ID: 9856717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass.
    Dowd NP; Karski JM; Cheng DC; Carroll JA; Lin Y; James RL; Butterworth J
    Anesthesiology; 2002 Aug; 97(2):390-9. PubMed ID: 12151929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic parameters relevant to recovery from opioids.
    Youngs EJ; Shafer SL
    Anesthesiology; 1994 Oct; 81(4):833-42. PubMed ID: 7943834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.